AstraZeneca breathes sigh of relief as court blocks US Symbi...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster.

GSK hits trouble with Trelegy as EU regulators block asthma ...

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of fl

Health Innovators: David Van Sickle on digital innovation in...

In the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Propeller Health about how digital technologies are revolutionising the field of respira

Inhale, Exhale: Living with Severe Asthma and Severe Eosinop...

Findings from patient research about severe asthma

Teva launches digital asthma and COPD rescue inhaler in US

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. 

Novartis on point in EU for asthma triple as CHMP backs Ener...